Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
X
Announcing new Tapestri Platform updates including lowered input threshold and expanded heme-onc menu. Learn More
X
Scientific presentation

Single-cell DNA-Seq publication roundup: conducting large-scale studies to understand therapy resistance, remission, and relapse


Kelly Kaihara, PhD
Description

Dr. Kelly Kaihara, from Mission Bio, reviews a series of publications from pharma and academic researchers that follow up on large-scale clinical trials and use single-cell DNA sequencing to better understand therapy resistance, remission, and relapse.

Publications reviewed include:
Molecular mechanisms mediating relapse following ivosidenib monotherapy in IDH1-mutant relapsed or refractory AML. Choe et al. Blood Advances 2020
Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML. DiNardo, C.D. et al. Blood 2020
Single-cell mutational profiling enhances the clinical evaluation of AML MRD. Ediriwickrema, A. et al. Blood Advances 2020
V211D Mutation in MEK1 Causes Resistance to MEK Inhibitors in Colon Cancer. Gao, Y. et al. Cancer Discovery 2019



VIEW


Scientific presentation
Do More Single Cell with Less – Tapestri Platform Expansion for Hematologic Malignancy Research
Koichi Takahashi, MD, PhD, MD Anderson Cancer Center & Jim Flynn, PhD, Mission Bio
(2021)
Scientific presentation
Women in Single Cell: Elucidating Clonal Evolution and Clonotype-Immunophenotype Relationships in Myeloid Malignancies with Single-Cell Analysis
Linde Miles, PhD, Memorial Sloan Kettering Cancer Center
(2021)
Scientific presentation
Meet the Authors: Single-cell Multiomics Analysis of Clonal Evolution in Myeloid Malignancies
Ross Levine, MD, Memorial Sloan Kettering Cancer Center
(2021)
Scientific presentation
Utilizing Single-Cell Multi-Omics to Uncover its Evolution and Resistance Mechanisms of AML
Cathy Smith, MD, UCSF
(2021)
REQUEST QUOTE